Abstracts tagged "MRI"

Abstract Number: 1870 • 2016 ACR/ARHP Annual Meeting
First Pilot Study of an Implantable Loop Recorder (ILR) in Systemic Sclerosis Detects Significant Cardiac Arrhythmias with CMR Abnormalities
Lesley-Anne Bissell¹, Bianca Dumitru¹, Giuseppina Abignano¹, Bara Erhayiem², Graham Fent², Peter Swoboda², Adam McDiarmid², John Greenwood², Francesco Del Galdo¹, Jacqueline Andrews¹, Sven Plein², Lee Graham² and Maya Buch¹, ¹Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, ²Multidisciplinary Cardiovascular Research Centre & The Division of Cardiovascular and Diabetes Research, LIGHT, University of Leeds, Leeds, United Kingdom
Background/Purpose: SSc-cardiomyopathy associated conduction abnormalities carry a poor prognosis, but their pathogenesis is unclear. Early detection to prevent complications is essential. ILRs are well-established in…
Abstract Number: 151 • 2016 ACR/ARHP Annual Meeting
Distinct Phenotypes in Palindromic Rheumatism: Ultrasound and MRI during Palindromic Flares
Kulveer Mankia¹, Maria Antonietta D'Agostino¹, Laura Horton¹, Jackie L. Nam², Jane E. Freeston³, Andrew J. Grainger⁴ and Paul Emery⁵, ¹Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK, Leeds, United Kingdom, ²Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, ³NIHR Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom, ⁴U Leeds, Leeds, United Kingdom, ⁵NIHR-Leeds Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom
Background/Purpose: Palindromic rheumatism (PR) is defined as a recurrent, self-abortive arthritis and/or para-arthritis, which progresses to RA in up to 50% patients (pts), particularly…
Abstract Number: 1017 • 2016 ACR/ARHP Annual Meeting
Statistical Simulation Using Data from the Foundation for the National Institute of Health/Osteoarthritis Initiative Biomarkers Consortium to Evaluate the Clinical Utility of Prognostic Knee Osteoarthritis Biomarkers in Designing a Knee Osteoarthritis Clinical Trial
Sheng Feng¹, Zheng (Roger) Liu², Feng Hong¹, Jeroen Medema¹, Rajesh Kamath¹ and Marc C. Levesque¹, ¹AbbVie Bioresearch Center, Worcester, MA, ²AbbVie Inc, AbbVie Bioresearch Center, Worcester, MA
Background/Purpose: Development of disease-modifying osteoarthritis drugs (DMOADs) for knee osteoarthritis (OA) has been challenging, partially owing to lack of prognostic biomarkers. Our objective was to…
Abstract Number: 2308 • 2016 ACR/ARHP Annual Meeting
Thigh Muscle MRI Reveals Extensive Muscle Edema and Early Fatty Replacement in Patients with Immune-Mediated Necrotizing Myopathy
Iago Pinal-Fernandez¹, Maria Casal-Dominguez², John A. Carrino³, Arash Lahoutiharahdashti², Pari Basharat⁴, Jemima Albayda², Julie J. Paik², Shivani Ahlawat⁵, Sonye K. Danoff⁶, Thomas E. Lloyd⁷, Andrew Mammen⁸ and Lisa Christopher-Stine⁶, ¹Muscle Diseases Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases. National Institutes of Health, Bethesda, MD, ²Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ³Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, ⁴Rheumatology, University of Western Ontario, London, ON, Canada, ⁵Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, ⁶Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, ⁷Neurology, Johns Hopkins, Baltimore, MD, ⁸National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD
Background/Purpose: The aim of this study was to define the pattern of muscle involvement in patients with immune-mediated necrotizing myopathy (IMNM). Methods: All Johns Hopkins…
Abstract Number: 169 • 2016 ACR/ARHP Annual Meeting
Ultrasound and Magnetic Resonance Imaging Fusion of Images and B-Flow Evaluation of Tenosynovitis – a Pilot Study on New Imaging Techniques in Rheumatoid Arthritis Patients
Mads Ammitzbøll-Danielsen^1,2, Daniel Glinatsi^2,3, Søren Torp-Pedersen⁴, Esperanza Naredo⁵, Mikkel Ostergaard² and Lene Terslev⁶, ¹Center for Rheumatology and Spine Diseases, Rigshospitalet - Glostrup, Copenhagen Center for Arthritis Research (COPECARE), Copenhagen, Denmark, ²Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark, ³Center for Rheumatology and Spine Diseases, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark, Glostrup, Denmark, ⁴Department of Diagnostics, Rigshospitalet, Glostrup, Copenhagen, Denmark, ⁵Rheumatology, Hospital General Universitario Gregorio Marañón and Universidad Complutense, Madrid, Spain, ⁶Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Copenhagen Center for Arthritis Research (COPECARE), Copenhagen, Denmark
Background/Purpose: Image fusion is an advanced imaging technology, which enables fusion of ultrasound (US) and magnetic resonance imaging (MRI). This fusion gives for each…
Abstract Number: 1021 • 2016 ACR/ARHP Annual Meeting
Maintaining Sufficient Serum Vitamin D Levels over 2 Years Is Associated with Reduced Knee Structural and Symptomatic Changes in Patients with Knee Osteoarthritis
Shuang Zheng¹, Xingzhong Jin¹, Flavia M Cicuttini², Xia Wang¹, Zhaohua Zhu¹, Anita E Wluka³, Weiyu Han¹, Tania Winzenberg¹, Leigh Blizzard¹, Graeme Jones⁴ and Changhai Ding⁴, ¹Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia, ²Monash University, Department of Epidemiology and Preventive Medicine, Melbourne, Australia, ³Australia, Armadale, Australia, ⁴Musculoskeletal Unit, Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia
Background/Purpose: To examine whether those maintaining sufficient serum vitamin D levels have reduced knee structural changes and symptomatic improvement compared with those not maintaining sufficient…
Abstract Number: 2347 • 2016 ACR/ARHP Annual Meeting
Serum Levels of Resistin Are Associated with Synovial Inflammation and Knee Structural Changes in Patients with Symptomatic Knee Osteoarthritis
WEIYU HAN¹, Flavia M Cicuttini², Graeme Jones³ and Changhai Ding³, ¹Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia, ²Monash University, Department of Epidemiology and Preventive Medicine, Melbourne, Australia, ³Musculoskeletal Unit, Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia
Background/Purpose: Due to these sparse and inconsistent clinical data, our current study aims to describe the associations between serum levels of resistin, knee synovial inflammation…
Abstract Number: 302 • 2016 ACR/ARHP Annual Meeting
Long-Lasting Local Knee Structural Pathology Is Associated with Persistent Multi-Site Pain
Feng Pan¹, Jing Tian², Dawn Aitken³, Flavia M Cicuttini⁴, Changhai Ding³ and Graeme Jones³, ¹Musculoskeletal Unit, Menzies Institute for Medical Research, University of Tasmania, Hobart,7000, Australia, ²Public health unit, Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia, ³Musculoskeletal Unit, Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia, ⁴Monash University, Department of Epidemiology and Preventive Medicine, Melbourne, Australia
Background/Purpose: Knee pain is the most common manifestation of knee osteoarthritis (OA) and typically accompanied by pain at other sites. Knee structural pathology in MRI,…
Abstract Number: 1044 • 2016 ACR/ARHP Annual Meeting
Treatment with Tofacitinib Is Associated with Clinically Meaningful Reductions in Axial MRI Inflammation in Patients with Ankylosing Spondylitis
Walter Maksymowych¹, Désirée van der Heijde², Xenofon Baraliakos³, Atul A. Deodhar⁴, Matt Brown⁵, Sarah Sherlock⁶, David Li⁷, Dona Fleishaker⁸ and Thijs Hendrikx⁷, ¹Department of Medicine, University of Alberta, Edmonton, AB, Canada, ²Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ³Rheumazentrum Ruhrgebiet, Herne, Germany, ⁴Division of Arthritis and Rheumatic Diseases, Oregon Health and Science University, Portland, OR, ⁵Institute for Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia, ⁶Pfizer Inc, Cambridge, MA, ⁷Pfizer Inc, Collegeville, PA, ⁸Pfizer Inc, Groton, CT
Background/Purpose: Tofacitinib is an oral Janus kinase inhibitor. Minimum clinically important differences (MCID) for SPondyloArthritis Research Consortium of Canada (SPARCC) MRI SI joint and spine…
Abstract Number: 2484 • 2016 ACR/ARHP Annual Meeting
Real World Treat to Target Strategy in Rheumatoid Arthritis: Radiograph and MRI Outcomes in Three Cohorts with 18 Month Follow up
Paul Bird¹, Maureen Rischmueller², Marie Feletar³, Gail Grant⁴, Margaret P. Staples⁵ and Stephen Hall⁶, ¹Medicine, University of New South Wales, Sydney, NSW, Australia, ²Rheumatology, The Queen Elizabeth Hospital, Adelaide, Australia, ³Department of Epidemiology and Preventive Medicine, Monash University, Dandenong, Australia, ⁴Emeritus Research, Malvern East, Australia, ⁵Monash Department of Clinical Epidemiology, Cabrini Institute and Monash University, Malvern, Australia, ⁶Cabrini Health and Monash University, Melbourne, VIC, Australia
Background/Purpose: The Treat to Target (TTT) model is well established in the treatment of rheumatic disease. Achieving DAS remission is one of the primary goals…
Abstract Number: 306 • 2016 ACR/ARHP Annual Meeting
MRI-Detected Cartilage Damage, Meniscal Damage, and Meniscal Extrusion Prior to Incident Radiographic Osteoarthritis and the Subsequent Trajectory of Joint Space Loss
C. Kent Kwoh¹, Frank Roemer^2,3, Erin L. Ashbeck⁴, Charles Ratzlaff⁴, Jeffrey Duryea⁵ and Ali Guermazi⁶, ¹1501 N. Campbell Avenue, Room 8303, The University of Arizona Arthritis Center, Tucson, AZ, ²Department of Radiology, Boston University School of Medicine, Boston, MA, ³Radiology, University of Erlangen, Erlangen, Germany, ⁴The University of Arizona Arthritis Center, Tucson, AZ, ⁵Radiology, Brigham & Women's Hospital/ Harvard Medical School, Boston, MA, ⁶Boston University School of Medicine, Boston, MA
Background/Purpose: Loss of joint space width (JSW) on x-ray is the recommended standard to define osteoarthritis progression. However, both cartilage and meniscal damage contribute to…
Abstract Number: 1293 • 2016 ACR/ARHP Annual Meeting
Utility of Extremity Magnetic Resonance Imaging (eMRI) without Contrast Enhancement in Detecting Preclinical Psoriatic Arthritis
Ashish J Mathew¹, Jyoti Panwar², Paul Bird³, Renu George⁴ and Debashish Danda¹, ¹Clinical Immunology & Rheumatology, Christian Medical College, Vellore, India, Vellore, India, ²Christian Medical College, Vellore, India, Vellore, India, ³University of New South Wales, Sydney, Australia, Sydney, NSW, Australia, ⁴Dermatology, Christian Medical College, Vellore, India, Vellore, India
Background/Purpose: Between 8-39% of patients with cutaneous psoriasis may develop psoriatic arthritis (PsA). Subclinical inflammatory joint disease in patients with psoriasis is common. i,ii This study…
Abstract Number: 2690 • 2016 ACR/ARHP Annual Meeting
Detection of Dorsal Root Ganglionitis with Magnetic Resonance Neurography in Sensory Ataxic Neuropathy Associated with SjöGren’s Syndrome
Takeshi Yoshida¹, Takeshi Sueyoshi², Shugo Suwazono³ and Mitsuyo Kinjo^4,5, ¹Internal Medicine, Okinawa Chubu Hospital, Uruma, Japan, ²Radiology, Minei Daiichi Hospital, Urasoe, Japan, ³Brain-Nerve-Muscle Research Center, National Hospital Organization Okinawa Hospital, Uruma, Japan, ⁴Rheumatology, Okinawa Chubu Hospital, Uruma, Japan, ⁵Internal Medicine, Okinawa Chubu Hospital, Uruma City Okinawa, Japan
Background/Purpose: Sensory ataxic neuropathy (SAN) is one of the neurologic complications in Sjögrenfs syndrome (SS). The underlying pathology was lymphocytic infiltration to the dorsal root…
Abstract Number: 315 • 2016 ACR/ARHP Annual Meeting
Hip Inflammation MRI Scoring System (HIMRISS) to Predict Response to Hyaluronic Acid (HAnox-M-XL) Injection in Hip Osteoarthritis
Nicolas Deseyne¹, Damien Loeuille², Thierry Conrozier³, Ulrich Weber⁴, Jacob Jaremko⁵, Henri Lellouche⁶, Bernard Maillet⁷, Joel Paschke⁸, Jonathan Epstein⁹ and Walter P. Maksymowych¹⁰, ¹Department of Rheumatology, CHRU Vandoeuvre les Nancy,, Vandoeuvre, France, ²Rheumatology, CHRU Nancy, Vandoeuvre les Nancy, France, ³Department of Rheumatology, North Hospital Franche-Comté, Belfort, France, ⁴Department of Research, King Christian 10th Hospital for Rheumatic Diseases, Graasten, Denmark, ⁵Radiology, Radiology, University of Alberta, Edmonton, AB, Canada, ⁶Department of Rheumatology, Lariboisière Hospital, Paris, France, Paris, France, ⁷Department of Rheumatology, Clinique Saint Odilon, Moulins, France, Moulins, France, ⁸CaRE Arthritis, Edmonton, AB, Canada, ⁹CEC-Inserm CIE6, Epidemiology and Clinical Evaluations Department, CHRU Vandoeuvre les Nancy, France, Vandoeuvre Les Nancy, France, ¹⁰Medicine, University of Alberta, Edmonton, AB, Canada
Background/Purpose: To assess predictors of response, according to hip MRI inflammatory scoring system (HIMRISS), in a sample of patients with hip osteoarthritis (OA) treated by…
Abstract Number: 1294 • 2016 ACR/ARHP Annual Meeting
Oblique Views Radiographs Have Advantages over Antero-Posterior View Radiographs in Assessing Sacroiliitis in Patients with Early Axial Spondyloarthritis
Zaiying Hu¹, Shanglin Zhu², Zetao Liao³, Baiyu Zhang² and Jieruo Gu⁴, ¹Department of Rheumatology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ²Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ³Rheumatology, 3rd Affiliated Hoapital of Sun Yat-Sen Uni, Guangzhou, China, ⁴Rheumatology, third affiliated hospital of Sun Yat-sen Universtiy, Guangzhou, China
Background/Purpose: All patients fulfilled the 2009 ASAS classification criteria for axial SpA. Three readers blinded (two radiologists and one rheumatologist) investigated the A-P view and…

« Previous Page
1
…
5
6
7
8
9
…
17
Next Page »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.